ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $431,000 | -29.0% | 8,892 | -42.7% | 0.10% | +3.0% |
| Q1 2018 | $607,000 | -11.8% | 15,531 | -4.2% | 0.10% | -19.4% |
| Q4 2017 | $688,000 | +11.7% | 16,212 | -1.9% | 0.12% | +8.8% |
| Q3 2017 | $616,000 | -15.0% | 16,521 | -30.8% | 0.11% | -27.8% |
| Q2 2017 | $725,000 | +14.7% | 23,878 | 0.0% | 0.16% | +32.8% |
| Q1 2017 | $632,000 | -6.6% | 23,878 | -10.1% | 0.12% | -7.8% |
| Q4 2016 | $677,000 | -81.7% | 26,565 | -75.5% | 0.13% | -66.1% |
| Q3 2016 | $3,691,000 | -11.7% | 108,632 | -11.7% | 0.38% | +5.2% |
| Q2 2016 | $4,181,000 | +25.0% | 123,065 | -2.9% | 0.36% | +46.6% |
| Q1 2016 | $3,344,000 | +19.7% | 126,726 | +56.1% | 0.25% | +384.3% |
| Q4 2015 | $2,794,000 | – | 81,176 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |